Clinical correlates of antifungal macrodilution susceptibility test results for non-AIDS patients with severe Candida infections treated with fluconazole

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 10, 2000, Pages 2715-2718

  Lee, S C ^a   Fung, C P ^a   Huang, J S ^a   Tsai, C J ^a   Chen, K S ^a   Chen, H Y ^a   Lee, N ^a   See, L C ^a   Shieh, W B ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDIASIS; CLINICAL ARTICLE; DOSE RESPONSE; DRUG SENSITIVITY; FEMALE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; REINFECTION; SUPERINFECTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; FEMALE; FLUCONAZOLE; HUMAN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME;

EID: 0033807952     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.10.2715-2718.2000     Document Type: Article

References (23)

1. Emerging pathogens
2. Correlation between in vitro and in vivo activity of antifungal agents against Candida species
3. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989
4. Variation in fluconazole therapy in Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model
5. Correlation of in vitro fluconazole resistance of candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1
6. Molecular karyotyping of multiple yeast species isolated from nine patients with AIDS during prolonged fluconazole therapy
7. Opportunistic candidiasis: An epidemic of the 1980s
8. CDC definitions for nosocomial infections 1988
9. Is there a correlation between serum antifungal drug concentration and clinical outcome?
10. Fluconazole-resistant Candida in AIDS patients: Report of two cases
11. Gram negative bacteremia. I. Etiology and ecology
12. Simple method for detecting fluconazole-resistant yeasts with chromogenic agar
13. Variation in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis
14. Evaluation of fluconazole in the treatment of oropharyngeal candidiasis in patients with AIDS
15. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: Documentation of in vitro susceptibility testing and DNA subtype analysis
16. A randomized trial comparing fluconazole with amphotedcin B for the treatment of candidemia in patients without neutropenia
17. Antifungal susceptibility testing of isolates from a randomized multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia
18. Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole and Candida infections
19. Activity of fluconazole and ketoconazole against Candida albicans in vitro and in vivo
20. Epidemiology of oral candidiasis in HIV-infected patients: Colonization, infection, treatment and emergence of fluconazole resistance
21. The prevalence of oral thrush and fluconazole resistant thrush in HIV+ patients